Bacterial profile and antimicrobial resistance to commonly used antimicrobials in intra-abdominal infections in two teaching hospitals

American Journal of Applied Sciences

Volumn 7, Issue 1, 2010, Pages 38-43

  Sepehri, Gholamreza ^a   Nejad, Hamid Zeinali ^b   Sepehri, Ehsan ^c   Razban, Saeideh ^d  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID BAHONAR UNIVERSITY OF KERMAN   (Iran)

Author keywords

Abdominal surgery; Antimicrobial resistance; Intra abdominal infections

Indexed keywords

EID: 75449115044     PISSN: 15469239     EISSN: 15543641     Source Type: Journal    
DOI: 10.3844/ajassp.2010.38.43     Document Type: Article

References (35)

1. Baron, E.J., R. Bennion, J. Thompson, C. Strong and P. Summanen et al., 1992. A microbiological comparison between acute and complicated appendicitis. Clin. Infect. Dis., 14: 227-231. http://www.ncbi.nlm.nih.gov/sites/entrez
2. Bennion, R.S., E.J. Baron, J.E. Thompson, J.R.J. Downes and P. Summanen et al., 1990. The bacteriology of gangrenous and perforated appendicitis-revisited. Ann. Surg., 211: 165-171. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC135 7960/?tool=pubmed
3. Blot, S. and J.J. De Waele. 2005. Critical issues in the clinical management of complicated intra-abdominal infections. Drugs, 65: 1611-1620. PMID: 16060697
4. Bohnen, J.M., 1992. Operative management of intra-abdominal infections. Infect. Dis. Clin. North Am., 6: 511-523. PMID: 1431036
5. Bohnen, J.M., J.S. Solomkin, E.P. Dellinger, H.S. Bjornson and C.P. Page, 1992. Guidelines for clinical care: Anti-infective agents for intra-abdominal infection. A surgical infection society policy statement. Arch. Surg., 127: 83-89. http://archsurg.ama-assn.org/cgi/reprint/127/1/83
6. De Francesco, M.A., G. Ravizzola, L. Peroni, R. Negrini and N. Manca, 2007. Urinary tract infections in Brescia, Italy: Etiology of uropathogens and antimicrobial resistance of common uropathogens. Med. Sci. Monit., 13: 136-144. http://www.medscimonit.com/fulltxt.php?ICID=48 4100
7. De Vera, M.E. and R.L. Simmons., 1996. Antibiotic-resistant enterococci and the changing face of surgical infections. Arch. Surg., 131: 338-342. http://archsurg.ama-assn.org/cgi/reprint/131/3/338
8. Dellinger, E.P., P.A. Gross, T.L. Barrett, P.J. Krause and W.J. Martone et al., 1994. Quality standard for antimicrobial prophylaxis in surgical procedures. Infectious diseases society of America. Clin. Infect. Dis., 18: 422-427. PMID: 8011827
9. Driscoll, J.A., S.L. Brody and M.H. Kollef, 2007. The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections. Drugs, 67: 351-368. PMID: 17335295
10. Ginocchio, C.C., 2002. Role of NCCLS in antimicrobial susceptibility testing and monitoring. Am. J. Health Syst. Pharm., 59: S7-11. http://www.ajhp.org/cgi/reprint/59/suppl_3/S7
11. Goldstein, E.J. and D.R. Snydman, 2004. Intra-abdominal infections: Review of the bacteriology, antimicrobial susceptibility and the role of ertapenem in their therapy. J. Antimicrob. Chemother., 53: 29-36. DOI: 10.1093/jac/dkh201
12. Goldstein, E.J., D.M. Citron, C. V. Merriam, Y. Warren and K.L. Tyrrell, 2000. Comparative in vitro activities of ertapenem (MK-0826) against 1,001 anaerobes isolated from human intra-abdominal infections. Antimicrob. Agents Chemother., 44: 2389-2394. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC90074/pdf/ac002389.pdf
13. Guembe, M., E. Cercenado, L. Alcala, M. Marin, R. Insa and E. Bouza, 2008. Evolution of antimicrobial susceptibility patterns of aerobic and facultative gram-negative bacilli causing intra-abdominal infections: Results from the SMART studies 2003-2007. Rev. Esp. Quimioter, 21: 166-173. http://seq.es/seq/0214-3429/21/3/guembe.pdf
14. Hasper, D., J.C. Schefold and D.C. Baumgart, 2009. Management of severe abdominal infections. Recent Pat. Antiinfect Drug. Discov., 4: 57-65. PMID: 19149697
15. Jouini, A., K.B. Slama, Y. Saenz, N. Klibi and D. Costa et al., 2009. Detection of multiple-antimicrobial resistance and characterization of the implicated genes in Escherichia coli isolates from foods of animal origin in Tunis. J. Food. Prot., 72: 1082-1088. PMID: 19517738
16. Koksal, F., K.A. kO. Kucukbasmaci and M. Samasti, 2009. Prevalence and antimicrobial resistance patterns of extended-spectrum beta-lactamaseproducing escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an istanbul university hospital. Chemotherapy, 55: 293-297. DOI: 10.1159/000224657
17. Kroenke, K., 1985. Polypharmacy. Causes, consequences and cure. Am. J. Med., 79: 149-152. PMID: 4025372
18. Laterre, P.F., F. Colardyn, M. Delmee, J. De Waele and J.C. Legrand et al., 2006. Antimicrobial therapy for intra-abdominal infections: Guidelines from the Infectious Disease Advisory Board (IDAB). Acta Chir. Belg., 106: 2-21. PMID: 16612906
19. Marshall, J.C., 2004. Intra-abdominal infections. Microbes Infect., 6: 1015-1025. DOI: 10.1016/J.MICINF.2004.05.017
20. Mazuski, J.E., 2007. Antimicrobial treatment for intra-abdominal infections. Exp. Opin. Pharmacother., 8: 2933-2945. DOI; 10.1517/14656566.8.17.2933
21. Mazuski, J.E., R.G. Sawyer, A.B. Nathens, J.T. DiPiro and M. Schein et al., 2002. The Surgical infection society guidelines on antimicrobial therapy for intra-abdominal infections: Evidence for the recommendations. Surg. Infect. Larchmt., 3: 175-233. DOI: 10.1089/109629602761624180
22. Mazuski, J.E., R.G. Sawyer, A.B. Nathens, J.T. DiPiro and M. Schein et al., 2002. The surgical infection society guidelines on antimicrobial therapy for intra-abdominal infections: An executive summary. Surg. Infect. Larchmt., 3: 161-173. DOI: 10.1089/109629602761624171
23. Mesaros, N., P. Nordmann, P. Plesiat, M. Roussel-Delvallez and J. Van Eldere et al., 2007. Pseudomonas aeruginosa: Resistance and therapeutic options at the turn of the new millennium. Clin. Microbiol. Infect., 13: 560-578. DOI: 10.1111/j.1469-0691.2007.01681.x
24. Montravers, P., A. Lepape, L. Dubreuil, R. Gauzit and Y. Pean et al., 2009. Clinical and microbiological profiles of community-acquired and nosocomial intra-abdominal infections: Results of the French prospective, observational EBIIA study. J. Antimicrob. Chemother., 63: 785-794. DOI: 10.1093/jac/dkp005
25. Obritsch, M.D., D.N. Fish, R. M. Laren and R. Jung, 2005. Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: Epidemiology and treatment options. Pharmacotherapy, 25: 1353-1364. DOI: 10.1592/phco.2005.25.10.1353
26. Onderdonk, A.B., R.L. Cisneros, R. Finberg, J.H. Crabb and D.L. Kasper, 1990. Animal model system for studying virulence of and host response to bacteroides fragilis. Rev. Infect. Dis., 12:169-177. PMID: 2406869
27. Paterson, D.L., F. Rossi, F. Baquero, P.R. Hsuehand G.L. Woods et al., 2005. In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: The 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART). J. Antimicrob. Chemother., 55: 965-973. DOI: 10.1093/jac/dki117
28. Pieracci, F.M. and P.S. Barie, 2007. Intra-abdominal infections. Curr. Opin. Crit. Care, 13: 440-449. DOI: 10.1097/MCC.0b013e32825a6720
29. Pieracci, F.M. and P.S. Barie., 2007. Management of severe sepsis of abdominal origin. Scand. J. Surg., 96: 184-196. http://www.fimnet.fi/sjs/articles/SJS32007-184.pdf
30. Schito, G.C., K.G. Naber, H. Botto, J. Palou and T. Mazzei et al., 2009. The ARESC study: An international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Int. J. Antimicrob. Agents, 34: 407-413. DOI: 10.1016/J.IJANTIMICAG.2009.04.012
31. Sepehri, G. and M.S. Meimandi, 2005. The quality of prescribing in general practice in Kerman, Iran. Int. J. Health Care Qual. Assur. Inc. Leadersh. Health Serv., 18: 353-360. PMID: 16167650
32. Smith, T.L., M.L. Pearson, K.R. Wilcox, C. Cruz and M.V. Lancaster et al., 1999. Emergence of vancomycin resistance in staphylococcus aureus. Glycopeptide-Intermediate staphylococcus aureus working group. N. Engl. J. Med., 340: 493-501. http://content.nejm.org/cgi/reprint/340/7/493.pdf
33. Solomkin, J.S., J.E. Mazuski, E.J. Baron, R.G. Sawyer and A.B. Nathens et al., 2003. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin. Infect. Dis., 37: 997-1005. DOI: 10.1086/378702
34. Weigelt, J.A., 2007. Empiric treatment options in the management of complicated intra-abdominal infections. Cleve. Clin. J. Med., 74:29-37. http://www.ccjm.org/content/74/Suppl_4/S29.long
35. Zapantis, A., M.K. Lacy, R.T. Horvat, D. Grauer and B.J. Barnes et al., 2005. Nationwide antibiogram analysis using NCCLS M39-a guidelines. J. Clin. Microbiol., 43: 2629-2634. DOI: 10.1128/JCM.43.6.2629-2634.2005